Wholesale of pharmaceutical and medical goods
BIO PHARMA NORWAY AS
Revenue 2024
NOK 1.9m
Operating profit
NOK −38,000
Equity
NOK 1.7m
Incorporated
2003
Share capital
NOK 136,000
Key figures · 2024
Current ratio
36.19
Equity ratio
45.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -2.0% | |
| Net margin (%%) | -3.2% | |
| Return on assets (%%) | -1.0% | |
| Likviditet | ||
| Current ratio | 36.19 | |
| Working capital | 3.2m | |
| Soliditet | ||
| Equity ratio (%%) | 45.2% | |
| Debt-to-equity ratio | 1.21 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.